PARG and central nervous system cancer: While as much as 40% of the glioma stem cells showed positive EdU incorporation following either DMSO, NRH or PARG inhibitor treatment, there was only a minimum EdU signal (< 5%), close to the negative control (2%), in the NRH/PARGi-treated cells (Figure 4E), indicating a block to DNA replication.